GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Neptunus Bioengineering Co Ltd (SZSE:000078) » Definitions » EV-to-EBITDA

Shenzhen Neptunus Bioengineering Co (SZSE:000078) EV-to-EBITDA : -23.02 (As of Jun. 23, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Shenzhen Neptunus Bioengineering Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Shenzhen Neptunus Bioengineering Co's enterprise value is ¥13,513 Mil. Shenzhen Neptunus Bioengineering Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-587 Mil. Therefore, Shenzhen Neptunus Bioengineering Co's EV-to-EBITDA for today is -23.02.

The historical rank and industry rank for Shenzhen Neptunus Bioengineering Co's EV-to-EBITDA or its related term are showing as below:

SZSE:000078' s EV-to-EBITDA Range Over the Past 10 Years
Min: -32.08   Med: 14.64   Max: 232.7
Current: -23.02

During the past 13 years, the highest EV-to-EBITDA of Shenzhen Neptunus Bioengineering Co was 232.70. The lowest was -32.08. And the median was 14.64.

SZSE:000078's EV-to-EBITDA is ranked worse than
100% of 708 companies
in the Drug Manufacturers industry
Industry Median: 14.185 vs SZSE:000078: -23.02

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-23), Shenzhen Neptunus Bioengineering Co's stock price is ¥2.13. Shenzhen Neptunus Bioengineering Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0.654. Therefore, Shenzhen Neptunus Bioengineering Co's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Shenzhen Neptunus Bioengineering Co EV-to-EBITDA Historical Data

The historical data trend for Shenzhen Neptunus Bioengineering Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Neptunus Bioengineering Co EV-to-EBITDA Chart

Shenzhen Neptunus Bioengineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.37 15.21 11.39 54.40 -76.88

Shenzhen Neptunus Bioengineering Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 209.48 123.57 94.13 -76.88 -26.16

Competitive Comparison of Shenzhen Neptunus Bioengineering Co's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Neptunus Bioengineering Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Neptunus Bioengineering Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Neptunus Bioengineering Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Shenzhen Neptunus Bioengineering Co's EV-to-EBITDA falls into.



Shenzhen Neptunus Bioengineering Co EV-to-EBITDA Calculation

Shenzhen Neptunus Bioengineering Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=13513.035/-586.977
=-23.02

Shenzhen Neptunus Bioengineering Co's current Enterprise Value is ¥13,513 Mil.
Shenzhen Neptunus Bioengineering Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-587 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen Neptunus Bioengineering Co  (SZSE:000078) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Shenzhen Neptunus Bioengineering Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.13/-0.654
=At Loss

Shenzhen Neptunus Bioengineering Co's share price for today is ¥2.13.
Shenzhen Neptunus Bioengineering Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.654.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Shenzhen Neptunus Bioengineering Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Shenzhen Neptunus Bioengineering Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Neptunus Bioengineering Co (SZSE:000078) Business Description

Traded in Other Exchanges
N/A
Address
Science and Technology Middle Road, 24th Floor, Haiwang Yinhe Technology Building, No. 1, Nanshan District, Guangdong, Shenzhen, CHN, 518057
Shenzhen Neptunus Bioengineering Co Ltd is primarily engaged in the research and development, manufacture and distribution of pharmaceutical products in China.
Executives
Shen Da Kai Directors, executives
Ren Ke Lei Independent director
Zhang Si Min Director
Zhang Yi Fei Directors, executives
Liu Zhan Jun Directors, executives
Zhang Quan Li Directors, Directors, and Executives
Song Ting Jiu Executives
Yu Lin Directors, executives
Feng Han Lin Supervisors
Zhang Wen Zhou Director
Nie Zhi Hua Supervisors
Huang Lei Executives
Zhang Li Jun Executives

Shenzhen Neptunus Bioengineering Co (SZSE:000078) Headlines

No Headlines